Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats

Chemical Research in Toxicology

Volumn 21, Issue 4, 2008, Pages 869-873

  Ip, Julia ^b   Wilson, John X ^b   Uetrecht, Jack P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CLOZAPINE;

AGRANULOCYTOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCORBIC ACID DEFICIENCY; BONE MARROW; COVALENT BOND; DRUG INDUCED DISEASE; DRUG PROTEIN BINDING; DRUG SYNTHESIS; FEMALE; GUINEA PIG; HYPOTHESIS; NONHUMAN; RAT; RISK FACTOR; SCHIZOPHRENIA;

AGRANULOCYTOSIS; ANIMALS; ANTIPSYCHOTIC AGENTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; CLOZAPINE; FEMALE; GUINEA PIGS; LEUKOCYTE COUNT; RATS; RISK FACTORS;

ANIMALIA; CAVIA; RATTUS;

EID: 43349083517     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx7004025     Document Type: Article

References (29)

1. Atkin, K., Kendall, F., Gould, D., Freeman, H., J., L., and D., O. S. (1996) The incidence of neutropenia and agranulocytosis in patients treated with clozapine in the UK and Ireland. Br. J. Psychiatry 169, 483-488.
2. Baldessarini, R. J., and Frankenburg, F. R. (1991) Clozapine. A novel antipsychotic agent. New Engl. J. Med. 324, 746-754.
3. Liu, Z. C., and Uetrecht, J. P. (1995) Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J. Pharmacol. Exp. Ther. 275, 1476-1483.
4. Maggs, J. L., Williams, D., Pirmohammed, M., and Park, B. K. (1995) The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J. Pharmacol. Exp. Ther. 275, 1463-1475.
5. Guest, I., Sokoluk, B., MacCrimmon, J., and Uetrecht, J. (1998) Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Toxicology 131, 53-65.
6. Pereira, A., and Dean, B. (2006) Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis. Biochem. Pharmacol. 72, 783-793.
7. Williams, D. P., Pirmohamed, M., Naisbitt, D. J., Uetrecht, J. P., and Park, B. K. (2000) Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol. Pharmacol. 58, 207-216.
8. Gardner, I., Zahid, N., MacCrimmon, D., and Uetrecht, J. P. (1998) A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. Mol. Pharmacol. 53, 991-998.
9. Tschen, A. C., Rieder, M. J., Oyewumi, L. K., and Freeman, D. J. (1999) The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis. Clin. Pharmacol. Ther. 65, 526-532.
10. Husain, Z., Almeciga, I., Delgado, J. C., Clavijo, O. P., Castro, J. E., Belalcazar, V., Pinto, C., Zuniga, J., Romero, V., and Yunis, E. J. (2006) Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine. Toxicol. Appl. Pharmacol. 214, 326-334.
11. Gardner, I., Leeder, J. S., Chin, T., Zahid, N., and Uetrecht, J. P. (1998) A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. Mol. Pharmacol. 53, 999-1008.
12. Jegouzo, A., Gressier, B., Frimat, B., Brunet, C., Dine, T., Luyckx, M., Kouach, M., Cazin, M., and Cazin, J. C. (1999) Comparative oxidation of loxapine and clozapine by human neutrophils. Fundam. Clin. Pharmacol. 13, 113-119.
13. Washko, P. W., Wang, Y., and Levine, M. (1993) Ascorbic acid recycling in human neutrophils. J. Biol. Chem. 268, 15531-15535.
14. Carr, A. C., and Frei, B. (1999) Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 69, 1086-1107.
15. Sirota, P., Gavrieli, R., and Wolach, B. (2003) Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity. Psychiatry Res. 121, 123-132.
16. Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., Tosic, M., Werge, T., and Do, K. Q. (2007) Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proc. Natl. Acad. Sci. U.S.A. 104, 16621-16626.
17. Mahadik, S. P., Evans, D., and Lal, H. (2001) Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol. Biol. Psychiatry 25, 463-493.
18. Cohen, S. A., and Paeglow, R. J. (2001) Scurvy: an unusual cause of anemia. J. Am. Board Fam. Pract. 14, 314-316.
19. Williams, D. P., Pirmohamed, M., Naisbitt, D. J., Maggs, J. L., and Park, B. K. (1997) Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J. Pharmacol. Exp. Ther. 283, 1375-1382.
20. Navia, J. M., and Hunt, C. E. (1976) Chapter 17: Nutrition, Nutritional Diseases, and Nutrition Research Applications, In The Biology of the Guinea Pig (Wagner, J. E., and Manning, P. J., Eds.) p 248, Academic Press,New York.
21. Horio, F., Ozaki, K., Yoshida, A., Makino, S., and Hayashi, Y. (1985) Requirement for ascorbic acid in a rat mutant unable to synthesize ascorbic acid. J. Nutr. 115, 1630-1640.
22. Wilson, J. X. (1990) Regulation of ascorbic acid concentration in embryonic chick brain. Dev. Biol. 139, 292-298.
23. Sisk, D. B. (1976) Chapter 7: Physiology, In The Biology of the Guinea Pig (Wagner, J. E. and Manning, P. J., Eds.) pp 67-72, Academic Press, New York.
24. Leonard, R., and Ruben, Z. (1986) Hematology values for peripheral blood of laboratory rats. Lab. Anim. Sci. 36, 227-231.
25. Suboticanec, K., Folnegovic-Smalc, V., Korbar, M., Mestrovic, B., and Buzina, R. (1990) Vitamin C status in chronic schizophrenia. Biol. Psychiatry 28, 959-966.
26. Fischer, V., Haar, J. A., Greiner, L., Lloyd, R. V., and Mason, R. P. (1991) Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. Mol. Pharmacol. 40, 846-853.
27. Killian, J. G., Kerr, K., Lawrence, C., and Celermajer, D. S. (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet 354, 1841-1845.
28. Williams, D. P., O'Donnell, C. J., Maggs, J. L., Leeder, J. S., Uetrecht, J., Pirmohamed, M., and Park, B. K. (2003) Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro. Chem. Res. Toxicol. 16, 1359-1364.
29. Wang, Y., Kashiba, M., Kasahara, E., Tsuchiya, M., Sato, E. F., Utsumi, K., and Inoue, M. (2001) Metabolic cooperation of ascorbic acid and glutathione in normal and vitamin C-deficient ODS rats. Physiol. Chem. Phys. Med. NMR 33, 29-39.